• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dihydroorotate dehydrogenase inhibitors: quantitative structure-activity relationship analysis.

作者信息

Ren S, Wu S K, Lien E J

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles 90033, USA.

出版信息

Pharm Res. 1998 Feb;15(2):286-95. doi: 10.1023/a:1011978904905.

DOI:10.1023/a:1011978904905
PMID:9523317
Abstract

PURPOSE

The main purpose of this study is to analyze the quantitative structure-activity relationship of two series of dihydroorotate dehydrogenase inhibitors (leflunomide and quinoline carboxylic acid analogues), and to determine the structural requirements for optimum activity of these analogues.

METHODS

A new CQSAR program was used in deriving regression equations and calculating the octanol/water partition coefficient and the molar refractivity values. The molecular modeling was performed using the HyperChem program.

RESULTS

Statistically significant correlations were obtained using a combination of 3-4 parameters. The structural requirements for optimum activity and critical regions for the inhibitory activity of dihydroorotate dehydrogenase were identified.

CONCLUSIONS

The quantitative structure-activity relationship analysis demonstrated that two series of dihydroorotate dehydrogenase inhibitors may bind to different binding sites on the enzyme. These results provide a better understanding of dihydroorotate dehydrogenase inhibitor-enzyme interactions, and may be useful for further modification and improvement of inhibitors of this important enzyme.

摘要

相似文献

1
Dihydroorotate dehydrogenase inhibitors: quantitative structure-activity relationship analysis.
Pharm Res. 1998 Feb;15(2):286-95. doi: 10.1023/a:1011978904905.
2
Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase.喹啉羧酸的构效关系。一类新型二氢乳清酸脱氢酶抑制剂。
Biochem Pharmacol. 1990 Aug 15;40(4):709-14. doi: 10.1016/0006-2952(90)90305-5.
3
Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.免疫抑制异恶唑和喹啉酸衍生物对人和大鼠二氢乳清酸脱氢酶的种属相关抑制作用。
Biochem Pharmacol. 1998 Nov 1;56(9):1259-64. doi: 10.1016/s0006-2952(98)00145-2.
4
Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.疟原虫二氢乳清酸脱氢酶的布雷喹那类似物抑制剂的合成。
Bioorg Med Chem. 2005 Mar 15;13(6):1945-67. doi: 10.1016/j.bmc.2005.01.017.
5
3D-QSAR studies on a series of dihydroorotate dehydrogenase inhibitors: analogues of the active metabolite of leflunomide.一系列二氢乳清酸脱氢酶抑制剂的3D-QSAR研究:来氟米特活性代谢物的类似物
Int J Mol Sci. 2011;12(5):2982-93. doi: 10.3390/ijms12052982. Epub 2011 May 10.
6
QSAR study on a series of aryl carboxylic acid amide derivatives as potential inhibitors of dihydroorotate dehydrogenase (DHODH).QSAR 研究一系列芳基羧酸酰胺衍生物作为二氢乳清酸脱氢酶(DHODH)潜在抑制剂。
Med Chem. 2013 Mar;9(2):222-39. doi: 10.2174/1573406411309020007.
7
Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid.阿托伐醌、紫铆因衍生物、布喹那钠和多孔菌酸对人和大鼠二氢乳清酸脱氢酶的抑制动力学
Chem Biol Interact. 2000 Jan 3;124(1):61-76. doi: 10.1016/s0009-2797(99)00144-1.
8
A carboxylic acid isostere screen of the DHODH inhibitor Brequinar.DHODH 抑制剂布雷奎纳的羧酸等排体筛选。
Bioorg Med Chem Lett. 2020 Nov 15;30(22):127589. doi: 10.1016/j.bmcl.2020.127589. Epub 2020 Sep 29.
9
Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase. A versatile tool to rate inhibitor effects?膜结合型小鼠、大鼠和人类黄素酶二氢乳清酸脱氢酶N端截短突变体的重组表达。一种评估抑制剂作用的通用工具?
Eur J Biochem. 2001 Mar;268(6):1861-8.
10
Tetrahydro-1H,5H-pyrazolo[1,2-a]pyrazole-1-carboxylates as inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.四氢-1H,5H-吡唑并[1,2-a]吡唑-1-羧酸酯类作为疟原虫二氢乳清酸脱氢酶的抑制剂。
Bioorg Chem. 2019 Aug;89:102982. doi: 10.1016/j.bioorg.2019.102982. Epub 2019 May 15.

引用本文的文献

1
Stereoselective Synthesis of Quaternary Pyrrolidine-2,3-diones and β-Amino Acids.立体选择性合成季戊四醇-2,3-二酮和β-氨基酸。
Org Lett. 2017 Jun 2;19(11):2961-2964. doi: 10.1021/acs.orglett.7b01185. Epub 2017 May 24.
2
Chemistry and biology of multicomponent reactions.多组分反应的化学与生物学
Chem Rev. 2012 Jun 13;112(6):3083-135. doi: 10.1021/cr100233r. Epub 2012 Mar 22.
3
3D-QSAR studies on a series of dihydroorotate dehydrogenase inhibitors: analogues of the active metabolite of leflunomide.一系列二氢乳清酸脱氢酶抑制剂的3D-QSAR研究:来氟米特活性代谢物的类似物

本文引用的文献

1
Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotate dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4'-(trifluoromethyl)phenyl ] propenamide and related compounds.二氢乳清酸脱氢酶抑制剂的合成、构效关系及药代动力学性质:2-氰基-3-环丙基-3-羟基-N-[3'-甲基-4'-(三氟甲基)苯基]丙烯酰胺及相关化合物
J Med Chem. 1996 Nov 8;39(23):4608-21. doi: 10.1021/jm9604437.
2
Cyclic modulation of enzymes of pyrimidine nucleotide biosynthesis precedes sialoglycoconjugate changes during 2-acetylaminofluorene-induced hepatocarcinogenesis in the rat.
Biochim Biophys Acta. 1984 Jul 30;800(2):194-201. doi: 10.1016/0304-4165(84)90060-6.
3
Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.癌细胞的生化策略与化疗设计:G. H. A. 克劳斯纪念讲座
Int J Mol Sci. 2011;12(5):2982-93. doi: 10.3390/ijms12052982. Epub 2011 May 10.
Cancer Res. 1983 Aug;43(8):3466-92.
4
Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis.动物体内嘧啶核苷酸的生物合成:基因、酶以及尿苷一磷酸生物合成的调控
Annu Rev Biochem. 1980;49:253-79. doi: 10.1146/annurev.bi.49.070180.001345.
5
The mechanism of action and mode of inhibition of dihydroorotate dehydrogenase. A quantum chemical study.二氢乳清酸脱氢酶的作用机制及抑制模式。一项量子化学研究。
Biochem Pharmacol. 1992 Jan 22;43(2):283-7. doi: 10.1016/0006-2952(92)90289-u.